1. Home
  2. VRAX vs SOPA Comparison

VRAX vs SOPA Comparison

Compare VRAX & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • SOPA
  • Stock Information
  • Founded
  • VRAX 2013
  • SOPA 2018
  • Country
  • VRAX United Kingdom
  • SOPA Singapore
  • Employees
  • VRAX N/A
  • SOPA N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SOPA EDP Services
  • Sector
  • VRAX Health Care
  • SOPA Technology
  • Exchange
  • VRAX Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • VRAX 5.9M
  • SOPA 6.3M
  • IPO Year
  • VRAX 2022
  • SOPA 2021
  • Fundamental
  • Price
  • VRAX $1.09
  • SOPA $0.83
  • Analyst Decision
  • VRAX Strong Buy
  • SOPA Buy
  • Analyst Count
  • VRAX 1
  • SOPA 2
  • Target Price
  • VRAX $3.00
  • SOPA $16.00
  • AVG Volume (30 Days)
  • VRAX 125.6K
  • SOPA 87.0K
  • Earning Date
  • VRAX 02-05-2025
  • SOPA 05-14-2025
  • Dividend Yield
  • VRAX N/A
  • SOPA N/A
  • EPS Growth
  • VRAX N/A
  • SOPA N/A
  • EPS
  • VRAX N/A
  • SOPA N/A
  • Revenue
  • VRAX $84,872.00
  • SOPA $6,906,240.00
  • Revenue This Year
  • VRAX $5,169.18
  • SOPA $7.97
  • Revenue Next Year
  • VRAX $66.97
  • SOPA $15.61
  • P/E Ratio
  • VRAX N/A
  • SOPA N/A
  • Revenue Growth
  • VRAX 7.03
  • SOPA N/A
  • 52 Week Low
  • VRAX $0.60
  • SOPA $0.73
  • 52 Week High
  • VRAX $9.00
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 32.51
  • SOPA 36.28
  • Support Level
  • VRAX $1.10
  • SOPA $0.88
  • Resistance Level
  • VRAX $1.35
  • SOPA $1.18
  • Average True Range (ATR)
  • VRAX 0.11
  • SOPA 0.09
  • MACD
  • VRAX 0.00
  • SOPA -0.00
  • Stochastic Oscillator
  • VRAX 6.77
  • SOPA 2.61

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: